These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21187564)

  • 1. Use of botulinum toxin in the treatment of lower urinary tract disorders. Current status.
    Mangera A; Chapple CR
    Arch Esp Urol; 2010 Dec; 63(10):829-41. PubMed ID: 21187564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin injection therapy in the management of lower urinary tract dysfunction.
    Patel AK; Chapple CR
    Int J Clin Pract Suppl; 2006 Dec; (151):1-7. PubMed ID: 17169004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin for the treatment of lower urinary tract symptoms: a review.
    Sahai A; Khan M; Fowler CJ; Dasgupta P
    Neurourol Urodyn; 2005; 24(1):2-12. PubMed ID: 15578628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin in urology: evaluation using an evidence-based medicine approach.
    Smith CP; Somogyi GT; Boone TB
    Nat Clin Pract Urol; 2004 Nov; 1(1):31-7. PubMed ID: 16474464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin injection for lower urinary tract dysfunction.
    Kuo YC; Kuo HC
    Int J Urol; 2013 Jan; 20(1):40-55. PubMed ID: 22571329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin in urinary incontinence.
    Patterson JM; Chapple CR
    Curr Opin Urol; 2006 Jul; 16(4):255-60. PubMed ID: 16770124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin in the management of lower urinary tract dysfunction: contemporary update.
    Cruz F; Silva C
    Curr Opin Urol; 2004 Nov; 14(6):329-34. PubMed ID: 15626874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature.
    Moore DC; Cohn JA; Dmochowski RR
    Toxins (Basel); 2016 Mar; 8(4):88. PubMed ID: 27023601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-neurogenic lower urinary tract dysfunction].
    Skobejko-Włodarska L
    Pol Merkur Lekarski; 2008; 24 Suppl 4():131-7. PubMed ID: 18924526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable neuromodulatory agents: botulinum toxin therapy.
    Frenkl TL; Rackley RR
    Urol Clin North Am; 2005 Feb; 32(1):89-99. PubMed ID: 15698881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection of botulinum toxin type A in the urethral sphincter to treat lower urinary tract dysfunction: a review of indications, techniques and results.
    Karsenty G; Baazeem A; Elzayat E; Corcos J
    Can J Urol; 2006 Apr; 13(2):3027-33. PubMed ID: 16672114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current information on sacral neuromodulation and botulinum toxin treatment for refractory idiopathic overactive bladder syndrome: a review.
    Leong RK; De Wachter SG; van Kerrebroeck PE
    Urol Int; 2010; 84(3):245-53. PubMed ID: 20389150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin treatment of urethral and bladder dysfunction.
    Chuang YC; Smith CP; Somogyi GT; Chancellor MB
    J Formos Med Assoc; 2003 Jan; 102(1):5-11. PubMed ID: 12684605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin for conditions of the female pelvis.
    El-Khawand D; Wehbe S; Whitmore K
    Int Urogynecol J; 2013 Jul; 24(7):1073-81. PubMed ID: 23344218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of botulinum toxin in the prostate.
    Chuang YC; Chancellor MB
    J Urol; 2006 Dec; 176(6 Pt 1):2375-82. PubMed ID: 17085104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urological applications of botulinum toxins].
    Karsenty G; Corcos J; Schurch B
    Prog Urol; 2006 Jun; 16(3):263-74. PubMed ID: 16821335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin for the lower urinary tract.
    Chuang YC; Kuo HC; Chancellor MB
    BJU Int; 2010 Apr; 105(8):1046-58. PubMed ID: 22299133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin for detrusor overactivity and symptoms of overactive bladder: where we are now and where we are going.
    Sahai A; Khan MS; Gregson N; Smith K; Dasgupta P;
    Nat Clin Pract Urol; 2007 Jul; 4(7):379-86. PubMed ID: 17615549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has botulinum toxin therapy come of age: what do we know, what do we need to know, and should we use it?
    da Silva CM; Cruz F
    Curr Opin Urol; 2009 Jul; 19(4):347-52. PubMed ID: 19444121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.